Risk and special populations
| Zeile 10: | Zeile 10: | ||
'''[[RSP - Pregnancy, Neonatology]]''' | '''[[RSP - Pregnancy, Neonatology]]''' | ||
| − | '''[[RSP - | + | '''[[RSP - Diabetes, Obesity]]''' |
'''[[RSP - Kidney disease]]''' | '''[[RSP - Kidney disease]]''' | ||
| Zeile 17: | Zeile 17: | ||
'''[[RSP - any on biologicals]]''' | '''[[RSP - any on biologicals]]''' | ||
| + | |||
| + | '''[[RSP - On RAS drugs]]''' | ||
| + | |||
| + | '''[[RSP - Smoking]]''' | ||
| + | |||
| + | '''[[RSP - Pulmonary disease]]''' | ||
| + | |||
| + | '''[[RSP - Cardiovascular disease]]''' | ||
| + | |||
| + | |||
| + | |||
| + | '''[[RSP - Cancer solid]]''' | ||
| + | |||
| + | '''[[RSP - Cancer hematology]]''' | ||
| + | |||
| + | '''[[RSP - Hematology other]]''' | ||
| + | |||
| + | '''[[RSP - HIV]]''' | ||
''' identifying factors ''' | ''' identifying factors ''' | ||
| Zeile 450: | Zeile 468: | ||
{{tp|p=32245656|t=2020. COVID-19 in patients with cardiovascular diseases |pdf=|usr=}} | {{tp|p=32245656|t=2020. COVID-19 in patients with cardiovascular diseases |pdf=|usr=}} | ||
üüüüüüü | üüüüüüü | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=32220865|t=2020. Non-steroidal anti-inflammatory drugs and covid-19 |pdf=|usr=}} | {{tp|p=32220865|t=2020. Non-steroidal anti-inflammatory drugs and covid-19 |pdf=|usr=}} | ||
{{tp|p=32205306|t=2020. Covid-19: European drugs agency to review safety of ibuprofen |pdf=|usr=}} | {{tp|p=32205306|t=2020. Covid-19: European drugs agency to review safety of ibuprofen |pdf=|usr=}} | ||
| Zeile 461: | Zeile 475: | ||
{{tp|p=32253225|t=2020. Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases |pdf=|usr=}} | {{tp|p=32253225|t=2020. Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases |pdf=|usr=}} | ||
{{tp|p=32369736|t=ä. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes |pdf=|usr=}} | {{tp|p=32369736|t=ä. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32291262|t=2020. Covid-19: Black people and other minorities are hardest hit in US |pdf=|usr=}} | {{tp|p=32291262|t=2020. Covid-19: Black people and other minorities are hardest hit in US |pdf=|usr=}} | ||
{{tp|p=32379903|t=2020. Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2 |pdf=|usr=}} | {{tp|p=32379903|t=2020. Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2 |pdf=|usr=}} | ||
| Zeile 467: | Zeile 481: | ||
{{tp|p=32369606|t=2020. COVID-19 Infection and Sickle Cell Disease: A UK Centre Experience |pdf=|usr=}} | {{tp|p=32369606|t=2020. COVID-19 Infection and Sickle Cell Disease: A UK Centre Experience |pdf=|usr=}} | ||
{{tp|p=32314798|t=2020. COVID-19 infection in patients with sickle cell disease |pdf=|usr=}} | {{tp|p=32314798|t=2020. COVID-19 infection in patients with sickle cell disease |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32312714|t=2020. COVID-19 More Frequent, Severe in Cancer Patients |pdf=|usr=}} | {{tp|p=32312714|t=2020. COVID-19 More Frequent, Severe in Cancer Patients |pdf=|usr=}} | ||
{{tp|p=32352633|t=2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients |pdf=|usr=}} | {{tp|p=32352633|t=2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients |pdf=|usr=}} | ||
| − | |||
| − | |||
| − | |||
{{tp|p=32339025|t=2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best Friend |pdf=|usr=}} | {{tp|p=32339025|t=2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best Friend |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32320270|t=2020. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms |pdf=|usr=}} | {{tp|p=32320270|t=2020. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32345646|t=2020. BTK inhibitors in cancer patients with COVID19: "The winner will be the one who controls that chaos" (Napoleon Bonaparte) |pdf=|usr=}} | {{tp|p=32345646|t=2020. BTK inhibitors in cancer patients with COVID19: "The winner will be the one who controls that chaos" (Napoleon Bonaparte) |pdf=|usr=}} | ||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=32342637|t=2020. COVID-19 and obesity |pdf=|usr=}} | {{tp|p=32342637|t=2020. COVID-19 and obesity |pdf=|usr=}} | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=32259878|t=ä. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID?19: Will cases of psoriasis increase after COVID?19 pandemic?|pdf=|usr=}} | {{tp|p=32259878|t=ä. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID?19: Will cases of psoriasis increase after COVID?19 pandemic?|pdf=|usr=}} | ||
| − | + | ||
| − | + | ||
{{tp|p=32233013|t=ä. Diabetes is a risk factor for the progression and prognosis of COVID?19 |pdf=|usr=}} | {{tp|p=32233013|t=ä. Diabetes is a risk factor for the progression and prognosis of COVID?19 |pdf=|usr=}} | ||
{{tp|p=32374012|t=2020. Mortality rate and gender differences in COVID-19 patients dying in Italy: A comparison with other countries |pdf=|usr=}} | {{tp|p=32374012|t=2020. Mortality rate and gender differences in COVID-19 patients dying in Italy: A comparison with other countries |pdf=|usr=}} | ||
| Zeile 496: | Zeile 506: | ||
{{tp|p=32369240|t=2020. Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind |pdf=|usr=}} | {{tp|p=32369240|t=2020. Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind |pdf=|usr=}} | ||
{{tp|p=32367558|t=2020. Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?|pdf=|usr=}} | {{tp|p=32367558|t=2020. Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?|pdf=|usr=}} | ||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=32259611|t=2020. COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used) |pdf=|usr=}} | {{tp|p=32259611|t=2020. COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used) |pdf=|usr=}} | ||
| − | |||
| − | |||
{{tp|p=32329083|t=2020. (ang.)COVID-19 transmission through host cell directed network of GPCR |pdf=|usr=}} | {{tp|p=32329083|t=2020. (ang.)COVID-19 transmission through host cell directed network of GPCR |pdf=|usr=}} | ||
{{tp|p=32234728|t=2020. EMA advice on the use of NSAIDs for Covid-19 |pdf=|usr=}} | {{tp|p=32234728|t=2020. EMA advice on the use of NSAIDs for Covid-19 |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32357072|t=2020. CLINICAL CHARACTERISTICS OF 28 PATIENTS WITH DIABETES AND COVID-19 IN WUHAN, CHINA |pdf=|usr=}} | {{tp|p=32357072|t=2020. CLINICAL CHARACTERISTICS OF 28 PATIENTS WITH DIABETES AND COVID-19 IN WUHAN, CHINA |pdf=|usr=}} | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=32239590|t=ä. Clinical findings in a patient with haemophilia A affected by COVID?19 |pdf=|usr=}} | {{tp|p=32239590|t=ä. Clinical findings in a patient with haemophilia A affected by COVID?19 |pdf=|usr=}} | ||
| − | |||
| − | + | ||
| + | |||
{{tp|p=32380214|t=ä. Clinical considerations for managing dermatology patients on systemic immunosuppressive and/or biologic therapy during COVID-19 pandemic |pdf=|usr=}} | {{tp|p=32380214|t=ä. Clinical considerations for managing dermatology patients on systemic immunosuppressive and/or biologic therapy during COVID-19 pandemic |pdf=|usr=}} | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=32310015|t=2020. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature |pdf=|usr=}} | {{tp|p=32310015|t=2020. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature |pdf=|usr=}} | ||
{{tp|p=32255507|t=2020. COVID-19 and Older Adults: What We Know |pdf=|usr=}} | {{tp|p=32255507|t=2020. COVID-19 and Older Adults: What We Know |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32376098|t=ä. A MULTINATIONAL REPORT TO CHARACTERISE SARS-CoV-2 INFECTION IN PEOPLE WITH CYSTIC FIBROSIS |pdf=|usr=}} | {{tp|p=32376098|t=ä. A MULTINATIONAL REPORT TO CHARACTERISE SARS-CoV-2 INFECTION IN PEOPLE WITH CYSTIC FIBROSIS |pdf=|usr=}} | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=32253888|t=2020. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection |pdf=|usr=}} | {{tp|p=32253888|t=2020. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32353193|t=2020. Is the type of diabetes treatment relevant to outcome of COVID-19?|pdf=|usr=}} | {{tp|p=32353193|t=2020. Is the type of diabetes treatment relevant to outcome of COVID-19?|pdf=|usr=}} | ||
{{tp|p=32162476|t=2020. Diabetes and COVID-19 |pdf=|usr=}} | {{tp|p=32162476|t=2020. Diabetes and COVID-19 |pdf=|usr=}} | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=32242993|t=2020. Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk |pdf=|usr=}} | {{tp|p=32242993|t=2020. Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk |pdf=|usr=}} | ||
| − | |||
| − | |||
{{tp|p=32220066|t=ä. SARS?CoV?2 and HIV |pdf=|usr=}} | {{tp|p=32220066|t=ä. SARS?CoV?2 and HIV |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32160316|t=ä. Co?infection of SARS?CoV?2 and HIV in a patient in Wuhan city, China |pdf=|usr=}} | {{tp|p=32160316|t=ä. Co?infection of SARS?CoV?2 and HIV in a patient in Wuhan city, China |pdf=|usr=}} | ||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=32369203|t=2020. Smoking links to the severity of Covid-19: An update of a meta-analysis |pdf=|usr=}} | {{tp|p=32369203|t=2020. Smoking links to the severity of Covid-19: An update of a meta-analysis |pdf=|usr=}} | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=32347975|t=2020. HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey |pdf=|usr=}} | {{tp|p=32347975|t=2020. HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey |pdf=|usr=}} | ||
{{tp|p=32343410|t=2020. COVID-19 in Tuberculosis patients: a report of three cases |pdf=|usr=}} | {{tp|p=32343410|t=2020. COVID-19 in Tuberculosis patients: a report of three cases |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32293753|t=2020. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis |pdf=|usr=}} | {{tp|p=32293753|t=2020. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis |pdf=|usr=}} | ||
{{tp|p=32293709|t=2020. Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better |pdf=|usr=}} | {{tp|p=32293709|t=2020. Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better |pdf=|usr=}} | ||
{{tp|p=32285949|t=2020. Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}} | {{tp|p=32285949|t=2020. Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32243919|t=2020. A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab |pdf=|usr=}} | {{tp|p=32243919|t=2020. A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32380044|t=ä. Obesity could shift severe COVID-19 disease to younger ages |pdf=|usr=}} | {{tp|p=32380044|t=ä. Obesity could shift severe COVID-19 disease to younger ages |pdf=|usr=}} | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=32251625|t=2020. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?|pdf=|usr=}} | {{tp|p=32251625|t=2020. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?|pdf=|usr=}} | ||
{{tp|p=32251539|t=2020. COVID-19 and liver disease |pdf=|usr=}} | {{tp|p=32251539|t=2020. COVID-19 and liver disease |pdf=|usr=}} | ||
{{tp|p=32329563|t=2020. Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis |pdf=|usr=}} | {{tp|p=32329563|t=2020. Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32377709|t=2020. Obesity - a risk factor for increased COVID-19 prevalence, severity and lethality |pdf=|usr=}} | {{tp|p=32377709|t=2020. Obesity - a risk factor for increased COVID-19 prevalence, severity and lethality |pdf=|usr=}} | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=32347572|t=2020. Outcome of Parkinson s Disease Patients Affected by COVID-19 |pdf=|usr=}} | {{tp|p=32347572|t=2020. Outcome of Parkinson s Disease Patients Affected by COVID-19 |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32281287|t=2020. Risk of COVID?19 for patients with obesity |pdf=|usr=}} | {{tp|p=32281287|t=2020. Risk of COVID?19 for patients with obesity |pdf=|usr=}} | ||
{{tp|p=32237212|t=ä. COVID 19 and the Patient with Obesity ? The Editors Speak Out |pdf=|usr=}} | {{tp|p=32237212|t=ä. COVID 19 and the Patient with Obesity ? The Editors Speak Out |pdf=|usr=}} | ||
| − | |||
| − | |||
{{tp|p=32365269|t=2020. Obesity and severe COVID-19 disease: a strong association |pdf=|usr=}} | {{tp|p=32365269|t=2020. Obesity and severe COVID-19 disease: a strong association |pdf=|usr=}} | ||
{{tp|p=32365275|t=2020. Obesity accompanying COVID-19: the role of epicardial fat |pdf=|usr=}} | {{tp|p=32365275|t=2020. Obesity accompanying COVID-19: the role of epicardial fat |pdf=|usr=}} | ||
| Zeile 607: | Zeile 582: | ||
{{tp|p=32286926|t=2020. Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19) infections and deaths?|pdf=|usr=}} | {{tp|p=32286926|t=2020. Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19) infections and deaths?|pdf=|usr=}} | ||
{{tp|p=32319118|t=2020. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover |pdf=|usr=}} | {{tp|p=32319118|t=2020. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32345686|t=2020. Vulnerable Youth and the COVID-19 Pandemic |pdf=|usr=}} | {{tp|p=32345686|t=2020. Vulnerable Youth and the COVID-19 Pandemic |pdf=|usr=}} | ||
{{tp|p=32317311|t=2020. Mitigating the Impacts of the COVID-19 Pandemic Response on At-Risk Children |pdf=|usr=}} | {{tp|p=32317311|t=2020. Mitigating the Impacts of the COVID-19 Pandemic Response on At-Risk Children |pdf=|usr=}} | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=32374541|t=2020. Diabete et infection a COVID-19 |pdf=|usr=}} | {{tp|p=32374541|t=2020. Diabete et infection a COVID-19 |pdf=|usr=}} | ||
{{tp|p=32348046|t=2020. Rhumatologie et COVID-19 |pdf=|usr=}} | {{tp|p=32348046|t=2020. Rhumatologie et COVID-19 |pdf=|usr=}} | ||
| Zeile 620: | Zeile 595: | ||
{{tp|p=32348044|t=2020. L'hematologie au temps du COVID-19 |pdf=|usr=}} | {{tp|p=32348044|t=2020. L'hematologie au temps du COVID-19 |pdf=|usr=}} | ||
{{tp|p=32348042|t=2020. Infection a SARS-CoV-2 et transplantation d'organes solides |pdf=|usr=}} | {{tp|p=32348042|t=2020. Infection a SARS-CoV-2 et transplantation d'organes solides |pdf=|usr=}} | ||
| − | + | ||
| − | + | ||
{{tp|p=32302282|t=2020. Sex- and Gender-specific Observations and Implications for COVID-19 |pdf=|usr=}} | {{tp|p=32302282|t=2020. Sex- and Gender-specific Observations and Implications for COVID-19 |pdf=|usr=}} | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=C7149289|t=2020. Regulatory agencies issue advice on use of NSAIDs for COVID-19 |pdf=|usr=}} | {{tp|p=C7149289|t=2020. Regulatory agencies issue advice on use of NSAIDs for COVID-19 |pdf=|usr=}} | ||
{{tp|p=C7187739|t=ä. Potential Impact of SARS-CoV-2 Infection in HIV-positive Patients in South Africa |pdf=|usr=}} | {{tp|p=C7187739|t=ä. Potential Impact of SARS-CoV-2 Infection in HIV-positive Patients in South Africa |pdf=|usr=}} | ||
| − | |||
| − | |||
| − | |||
{{tp|p=32430225|t=ä. Disparities in the Population at Risk of Severe Illness From COVID-19 by Race/Ethnicity and Income |pdf=|usr=}} | {{tp|p=32430225|t=ä. Disparities in the Population at Risk of Severe Illness From COVID-19 by Race/Ethnicity and Income |pdf=|usr=}} | ||
| − | |||
| − | + | ||
| + | |||
{{tp|p=32387456|t=ä. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532) |pdf=|usr=}} | {{tp|p=32387456|t=ä. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532) |pdf=|usr=}} | ||
| − | {{tp|p= | + | |
| − | + | {{tp|p=32387167|t=ä. The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019 |pdf=|usr=}} | |
{{tp|p=32376969|t=ä. COVID-19 outcomes in patients with hematologic disease |pdf=|usr=}} | {{tp|p=32376969|t=ä. COVID-19 outcomes in patients with hematologic disease |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32381262|t=ä. Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission |pdf=|usr=}} | {{tp|p=32381262|t=ä. Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission |pdf=|usr=}} | ||
| − | |||
| − | |||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=32402515|t=ä. Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis |pdf=|usr=}} | {{tp|p=32402515|t=ä. Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis |pdf=|usr=}} | ||
{{tp|p=32413819|t=2020. Vitamin D concentrations and COVID-19 infection in UK Biobank |pdf=|usr=}} | {{tp|p=32413819|t=2020. Vitamin D concentrations and COVID-19 infection in UK Biobank |pdf=|usr=}} | ||
| Zeile 673: | Zeile 623: | ||
{{tp|p=32388171|t=2020. SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome |pdf=|usr=}} | {{tp|p=32388171|t=2020. SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome |pdf=|usr=}} | ||
{{tp|p=32291196|t=2020. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?|pdf=|usr=}} | {{tp|p=32291196|t=2020. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?|pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32389521|t=2020. COVID-19 infection in patients following hepato-pancreatico-biliary intervention: An early experience |pdf=|usr=}} | {{tp|p=32389521|t=2020. COVID-19 infection in patients following hepato-pancreatico-biliary intervention: An early experience |pdf=|usr=}} | ||
| − | |||
| − | + | ||
| − | + | ||
| + | |||
{{tp|p=32376408|t=ä. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study |pdf=|usr=}} | {{tp|p=32376408|t=ä. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study |pdf=|usr=}} | ||
{{tp|p=C7128941|t=2020. COVID19 Presents High Risk to Older Persons |pdf=|usr=}} | {{tp|p=C7128941|t=2020. COVID19 Presents High Risk to Older Persons |pdf=|usr=}} | ||
{{tp|p=32376043|t=ä. Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak |pdf=|usr=}} | {{tp|p=32376043|t=ä. Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak |pdf=|usr=}} | ||
{{tp|p=32380288|t=ä. Genetic susceptibility for COVID-19?associated sudden cardiac death in African Americans |pdf=|usr=}} | {{tp|p=32380288|t=ä. Genetic susceptibility for COVID-19?associated sudden cardiac death in African Americans |pdf=|usr=}} | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=32376098|t=ä. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis |pdf=|usr=}} | {{tp|p=32376098|t=ä. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis |pdf=|usr=}} | ||
| − | |||
| − | |||
| − | + | ||
{{tp|p=32371279|t=ä. Therapeutic Strategy for Patients with Coronavirus Disease 2019 During Left Ventricular Assist Device Supports |pdf=|usr=}} | {{tp|p=32371279|t=ä. Therapeutic Strategy for Patients with Coronavirus Disease 2019 During Left Ventricular Assist Device Supports |pdf=|usr=}} | ||
{{tp|p=32305569|t=2020. Novel Coronavirus Disease 2019 in a Patient on Durable Left Ventricular Assist Device Support |pdf=|usr=}} | {{tp|p=32305569|t=2020. Novel Coronavirus Disease 2019 in a Patient on Durable Left Ventricular Assist Device Support |pdf=|usr=}} | ||
| − | |||
| − | |||
{{tp|p=32408961|t=ä. Clinical course of patients infected with severe acute respiratory syndrome coronavirus 2 soon after thoracoscopic lung surgery |pdf=|usr=}} | {{tp|p=32408961|t=ä. Clinical course of patients infected with severe acute respiratory syndrome coronavirus 2 soon after thoracoscopic lung surgery |pdf=|usr=}} | ||
{{tp|p=32292915|t=ä. Severe COVID-19 With ARDS in a Patient on Durable LVAD Support |pdf=|usr=}} | {{tp|p=32292915|t=ä. Severe COVID-19 With ARDS in a Patient on Durable LVAD Support |pdf=|usr=}} | ||
| Zeile 703: | Zeile 647: | ||
{{tp|p=32388230|t=2020. Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia |pdf=|usr=}} | {{tp|p=32388230|t=2020. Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia |pdf=|usr=}} | ||
{{tp|p=32389426|t=2020. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: ...|pdf=|usr=}} | {{tp|p=32389426|t=2020. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: ...|pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32475616|t=ä. copd w covid.... |pdf=|usr=}} | {{tp|p=32475616|t=ä. copd w covid.... |pdf=|usr=}} | ||
{{tp|p=32360210|t=2020. Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection |pdf=|usr=}} | {{tp|p=32360210|t=2020. Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32387757|t=2020. Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency?|pdf=|usr=}} | {{tp|p=32387757|t=2020. Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency?|pdf=|usr=}} | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=32382684|t=2020. The mutual effects of COVID-19 and obesity |pdf=|usr=}} | {{tp|p=32382684|t=2020. The mutual effects of COVID-19 and obesity |pdf=|usr=}} | ||
{{tp|p=32389584|t=ä. Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis |pdf=|usr=}} | {{tp|p=32389584|t=ä. Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32421537|t=2020. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19) |pdf=|usr=}} | {{tp|p=32421537|t=2020. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19) |pdf=|usr=}} | ||
Version vom 12. Juni 2020, 16:06 Uhr
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
which risk factors make covid worse/better/no effect
RSP - identifying risk factors
which characteristics has covid in a diseased patient with underlying disorder/state
identifying factors
Frailty
32268300 2020. Biomarkers of biological age as predictors of COVID-19 disease severity
32339960 2020. Clinical characteristics of older patients infected with COVID-19: A descriptive study
32331795 ä. Afectacion clinica y sintomatoligica en pacientes mayores de 65 anos por COVID-19
32269670 2020. Canadian Geriatrics Society COVID-19 Recommendations for Older Adults What Do Older Adults Need To Know?
Comorbidity
Diabetes, Obesity, low androgens
32249357 ä. Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic
32345580 2020. Diabetes and covid-19: a global health challenge
32345579 2020. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
Heart
32331955 ä. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis
32326691 2020. Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction
32277299 2020. Perspective: cardiovascular disease and the Covid-19 pandemic
32335068 ä. Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock
Cancer
32278878 ä. French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak
32345594 2020. Patients with Cancer Appear More Vulnerable to SARS-COV-2: A Multicenter Study during the COVID-19 Outbreak
HIV
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19
other pharmacology
Drug abuse
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19
modifiable - tobacco
32303807 ä. Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic
indoor livin ppl
Psychiatry
32294689 2020. Schizophrenia and COVID-19: risks and recommendations
32371563 2020. Asthma increases risk of severity of COVID-19
32334081 ä. HEALTH STATUS OF LIVER TRANSPLANTED PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTER EXPERIENCE FROM MILAN
32276139 2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
32276140 2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
32271368 ä. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission
32270178 ä. Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV
32353114 ä. Throat Wash Testing and COVID-19 Disease: Should We Put Our Money Where Our Mouth Is?
32161990 ä. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
32328736 ä. No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity
32357998 2020. Cardiac considerations in patients with COVID-19
32332038 2020. Asthma and COVID-19
32350632 2020. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty
32300516 ä. Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times
32298981 2020. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
32283499 2020. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
32334395 ä. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia ? A systematic review, meta-analysis, and meta-regression?
32228738 ä. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease
32256706 2020. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
32328575 ä. Age, frailty and diabetes ? triple jeopardy for vulnerability to COVID-19 infection
32322805 ä. SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19 in people living with HIV
32134381 2020. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China
32305831 ä. Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment
32232395 ä. Initial COVID-19 affecting cardiac patients in China
32344292 2020. COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors
32322046 ä. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China
32296994 ä. The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments
C7141546 ä. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?
32345527 ä. Smoking Habit and Hospitalization for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Related Pneumonia: the unsolved paradox behind the evidence
32269089 2020. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19
32341104 2020. Cardiovascular comorbidity and its impact on patients with Covid-19
32350104 ä. COVID-19 and Nicotine as a Mediator of ACE-2
32341101 2020. COVID-19 and Smoking Is Nicotine the Hidden Link?
32312864 ä. Association between ages and clinical characteristics and outcomes of coronavirus disease 2019
32284245 ä. The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is ?Safe Better than Sorry??
32222253 2020. COVID-19: lessons from the Italian reproductive medical experience
32323577 ä. What the oncologist needs to know about COVID-19 infection in cancer patients
32357575 2020. COVID-19: A Geriatric Emergency
32357582 2020. Ageing and COVID-19: What is the Role for Elderly People?
32274617 2020. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes
32199996 2020. Infection par le SARS-CoV-2 chez les femmes enceintes: etat des connaissances et proposition de prise en charge par CNGOF
32244059 ä. SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes
32302703 ä. Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment
32292696 ä. COVID-19 Infection Unmasking Brugada Syndrome
32325028 ä. G6PD deficiency in COVID-19 pandemic: ?a ghost in the ghost?
32342146 ä. COVID-19 pandemic: is a gender-defined dosage effect responsible for the high mortality rate among males?
32146921 ä. COVID-19 and gender-specific difference: Analysis of public surveillance data in Hong Kong and Shenzhen, China, from January 10 to February 15, 2020
32307025 ä. Could COVID-19 represent a negative prognostic factor in patients with stroke?
32335339 ä. Case Report: One Case of Coronavirus Desease 2019(COVID-19) in Patient Co-nfected by HIV With a Low CD4+ T Cell Count
32331343 2020. Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D
32355869 ä. The Dermatologist?s Perspective: Why is COVID-19 mortality lower in females than males?
32297089 ä. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
32333915 ä. Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2
32371047 ä. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic
32224277 2020. COVID-19 and immunomodulator/immunosuppressant use in dermatology
32199889 2020. Should biologics for psoriasis be interrupted in the era of COVID-19?
32283234 ä. Biologics for psoriasis during COVID-19 outbreak
32246966 ä. COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution
32305444 ä. COVID-19 and racial disparities
32283235 ä. Various forms of skin rash in COVID-19 : a reply
32283233 ä. Reply to ?COVID-19 can present with a rash and be mistaken for Dengue?: Petechial rash in a patient with COVID-19 infection
32330545 ä. African American COVID-19 Mortality: A Sentinel Event
32154911 2020. COVID?19 Presents High Risk to Older Persons
32347144 2020. Current perspectives on Coronavirus 2019 (COVID-19) and cardiovascular disease: A white paper by the JAHA editors
32253068 2020. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
32370269 2020. Smoking and SARS-CoV-2 Disease (COVID-19): Dangerous Liaisons or Confusing Relationships?
32244852 2020. Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19)
32222956 ä. Prevalence and impact of diabetes among people infected with SARS-CoV-2
32300796 ä. A geroscience perspective on COVID-19 mortality
32279081 ä. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study
32360995 ä. No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease
32278005 ä. Non-alcoholic fatty liver diseases in patients with COVID-19: A etrospective study
32348791 ä. Clinical characteristics of COVID-19 patients with abnormal liver tests
32348790 ä. Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis
32305291 ä. Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury
32240670 2020. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up
32171866 ä. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients
32147409 ä. Are children less susceptible to COVID-19?
32366317 2020. Covid-19?The real role of NSAIDs in Italy
32306369 ä. The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities
32335513 2020. Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis
| 32335512 2020. Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs |
32373791 ä. Sex Differences in Mortality from COVID-19 Pandemic: Are Men Vulnerable and Women Protected?
{{tp|p=32302293|t=2020. COVID-19 in older adults: clinical, psychosocial, and public health considerations |pdf=|usr=}
32278370 2020. The gendered dimensions of COVID-19
32334645 2020. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection
32359411 ä. COVID-19 and obesity?lack of clarity, guidance, and implications for care
32171057 2020. Implications of COVID-19 for patients with pre-existing digestive diseases
32304642 ä. COVID-19 in patients with HIV: clinical case series
32224304 2020. COVID-19 infection in children
32171067 2020. Sex difference and smoking predisposition in patients with COVID-19
32171062 2020. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
32332856 ä. COVID-19 in persons with haematological cancers
32353398 ä. Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China
32344304 ä. May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications ?
32339776 2020. Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of disease
32333196 2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
32271125 2020. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
32220612 2020. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China
32220611 2020. Commentary: COVID-19 in patients with diabetes
32275971 ä. COVID-19 in patients with diabetes: risk factors that increase morbidity
32360211 ä. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32360397 ä. Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy
32353356 ä. Obesity: the ?Achilles heel? for COVID-19?
32333939 2020. Importance of metabolic health in the era of COVID-19
32333938 2020. Obesity hypoventilation syndrome and severe COVID-19
32320741 2020. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32320742 ä. COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next?
32271728 2020. Coronavirus Disease 2019 in Children - United States, February 12?April 2, 2020
32345328 2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
32218613 ä. Coronaviruserkrankung bei Kindern ? erste Daten aus Wuhan
| 32317808 ä. COVID-19 bei hospitalisierten Kindern und Jugendlichen: Ein systematischer Review zu publizierten Fallserien (Stand 31 03 2020) und erste Daten aus Deutschland |
32187458 ä. SARS-CoV-2 Infection in Children
32163697 2020. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China
32265531 ä. COVID-19 and cancer: what we know so far
32346090 ä. Does asthma make COVID-19 worse?
32283004 ä. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
32346676 ä. Crowdsourcing a crisis response for COVID-19 in oncology
32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
32327737 ä. Obesity and impaired metabolic health in patients with COVID-19
32303856 ä. Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
32270359 ä. Acute stroke management pathway during Coronavirus-19 pandemic
32270358 ä. No lockdown for neurological diseases during COVID19 pandemic infection
32364125 ä. Consulta de epilepsia durante la pandemia de Covid-19: papel de la telemedicina y efectos del confinamiento en pacientes epil�pticos
32364122 ä. Neuroinfecciones en tiempos de COVID-19
32333196 2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
32271125 2020. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
32220612 2020. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China
32220611 2020. Commentary: COVID-19 in patients with diabetes
32275971 ä. COVID-19 in patients with diabetes: risk factors that increase morbidity
32360211 ä. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32360397 ä. Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy
32353356 ä. Obesity: the ?Achilles heel? for COVID-19?
32333939 2020. Importance of metabolic health in the era of COVID-19
32333938 2020. Obesity hypoventilation syndrome and severe COVID-19
32320741 2020. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32320742 ä. COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next?
32271728 2020. Coronavirus Disease 2019 in Children - United States, February 12?April 2, 2020
32345328 2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
32218613 ä. Coronaviruserkrankung bei Kindern ? erste Daten aus Wuhan
| 32317808 ä. COVID-19 bei hospitalisierten Kindern und Jugendlichen: Ein systematischer Review zu publizierten Fallserien (Stand 31 03 2020) und erste Daten aus Deutschland |
32187458 ä. SARS-CoV-2 Infection in Children
32163697 2020. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China
32265531 ä. COVID-19 and cancer: what we know so far
32346090 ä. Does asthma make COVID-19 worse?
32346676 ä. Crowdsourcing a crisis response for COVID-19 in oncology
32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
32327737 ä. Obesity and impaired metabolic health in patients with COVID-19
32203970 ä. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade
32311696 ä. Comment on ?Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade?
32371550 2020. COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
32303856 ä. Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
32270359 ä. Acute stroke management pathway during Coronavirus-19 pandemic
32270358 ä. No lockdown for neurological diseases during COVID19 pandemic infection
32364125 ä. Consulta de epilepsia durante la pandemia de Covid-19: papel de la telemedicina y efectos del confinamiento en pacientes epil�pticos
32364122 ä. Neuroinfecciones en tiempos de COVID-19
32333196 2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
32271125 2020. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
32220612 2020. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China
32220611 2020. Commentary: COVID-19 in patients with diabetes
32275971 ä. COVID-19 in patients with diabetes: risk factors that increase morbidity
32360211 ä. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32360397 ä. Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy
32353356 ä. Obesity: the ?Achilles heel? for COVID-19?
32333939 2020. Importance of metabolic health in the era of COVID-19
32333938 2020. Obesity hypoventilation syndrome and severe COVID-19
32320741 2020. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32320742 ä. COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next?
32271728 2020. Coronavirus Disease 2019 in Children - United States, February 12?April 2, 2020
32345328 2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
32218613 ä. Coronaviruserkrankung bei Kindern ? erste Daten aus Wuhan
| 32317808 ä. COVID-19 bei hospitalisierten Kindern und Jugendlichen: Ein systematischer Review zu publizierten Fallserien (Stand 31 03 2020) und erste Daten aus Deutschland |
32187458 ä. SARS-CoV-2 Infection in Children
32163697 2020. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China
32302077 ä. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China
32265531 ä. COVID-19 and cancer: what we know so far
32346090 ä. Does asthma make COVID-19 worse?
32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
32327737 ä. Obesity and impaired metabolic health in patients with COVID-19
32270359 ä. Acute stroke management pathway during Coronavirus-19 pandemic
32270358 ä. No lockdown for neurological diseases during COVID19 pandemic infection
32364125 ä. Consulta de epilepsia durante la pandemia de Covid-19: papel de la telemedicina y efectos del confinamiento en pacientes epilepticos
32364122 ä. Neuroinfecciones en tiempos de COVID-19
32372822 2020. Why are ethnic minorities worse affected?
32372818 2020. Men hit harder by covid-19
32372803 2020. Children and covid-19
32243722 2020. Lessons unfolding from pediatric cases of COVID?19 disease caused by SARS?CoV?2 infection
32360482 2020. NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?
32343745 2020. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients
32231171 2020. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis
32343807 ä. The Elderly & COVID-19: Cocooning or Culling: - the choice is ours
32289171 ä. Cardiac drugs and outcome in COVID-19: Reply
32289168 ä. Cardiac drugs and outcome in COVID - 19
C7129713 ä. Coronavirus: la emergencia geri�trica de 2020 Documento conjunto de la Secci�n de Cardiolog�a Geri�trica de la Sociedad Espa�ola de Cardiolog�a y la Sociedad Espa�ola de Geriatr�a y Gerontolog�a
32331829 ä. Smoking and coronavirus disease 2019 (COVID-19)
32336968 2020. COVID-19 outbreak impact in Spain: A role for tobacco smoking?
32206052 2020. COVID-19 and smoking: A systematic review of the evidence
32355638 ä. Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
32377677 ä. COVID-19 in Older People: A Rapid Clinical Review
32228252 2020. COVID-19, ACE2, and the cardiovascular consequences
32212348 2020. Why is COVID-19 so mild in children?
32339307 2020. Additional hypotheses about why COVID-19 is milder in children than adults
32279351 2020. We urgently need guidelines for managing COVID-19 in children with comorbidities
32310898 2020. Infection of severe acute respiratory syndrome coronavirus 2 in a patient with acquired immunodeficiency syndrome
32358994 2020. Asthma and COVID-19: is asthma a risk factor for severe outcomes?
32311145 2020. SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience
32243621 2020. COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient
32267016 2020. Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19)
32329629 2020. Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2
32339251 2020. The importance of hypertension as a risk factor for severe illness and mortality in COVID-19
32243894 2020. COVID-19 infection in cancer patients: early observations and unanswered questions
32224151 2020. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
32321720 2020. Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)
32245656 2020. COVID-19 in patients with cardiovascular diseases
üüüüüüü
32220865 2020. Non-steroidal anti-inflammatory drugs and covid-19
32205306 2020. Covid-19: European drugs agency to review safety of ibuprofen
32184201 2020. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists
32253225 2020. Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases
32369736 ä. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
32291262 2020. Covid-19: Black people and other minorities are hardest hit in US
32379903 2020. Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2
32369615 2020. Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression
32369606 2020. COVID-19 Infection and Sickle Cell Disease: A UK Centre Experience
32314798 2020. COVID-19 infection in patients with sickle cell disease
32312714 2020. COVID-19 More Frequent, Severe in Cancer Patients
32352633 2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients
32339025 2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best Friend
32320270 2020. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms
32345646 2020. BTK inhibitors in cancer patients with COVID19: "The winner will be the one who controls that chaos" (Napoleon Bonaparte)
32342637 2020. COVID-19 and obesity
32259878 ä. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID?19: Will cases of psoriasis increase after COVID?19 pandemic?
32233013 ä. Diabetes is a risk factor for the progression and prognosis of COVID?19
32374012 2020. Mortality rate and gender differences in COVID-19 patients dying in Italy: A comparison with other countries
32189428 ä. Is nicotine exposure linked to cardiopulmonary vulnerability to COVID?19 in the general population?
32376408 ä. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study
32369240 2020. Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind
32367558 2020. Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?
32259611 2020. COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used)
32329083 2020. (ang.)COVID-19 transmission through host cell directed network of GPCR
32234728 2020. EMA advice on the use of NSAIDs for Covid-19
32357072 2020. CLINICAL CHARACTERISTICS OF 28 PATIENTS WITH DIABETES AND COVID-19 IN WUHAN, CHINA
32239590 ä. Clinical findings in a patient with haemophilia A affected by COVID?19
32380214 ä. Clinical considerations for managing dermatology patients on systemic immunosuppressive and/or biologic therapy during COVID-19 pandemic
32310015 2020. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature
32255507 2020. COVID-19 and Older Adults: What We Know
32376098 ä. A MULTINATIONAL REPORT TO CHARACTERISE SARS-CoV-2 INFECTION IN PEOPLE WITH CYSTIC FIBROSIS
32253888 2020. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection
32353193 2020. Is the type of diabetes treatment relevant to outcome of COVID-19?
32162476 2020. Diabetes and COVID-19
32242993 2020. Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk
32220066 ä. SARS?CoV?2 and HIV
32160316 ä. Co?infection of SARS?CoV?2 and HIV in a patient in Wuhan city, China
32369203 2020. Smoking links to the severity of Covid-19: An update of a meta-analysis
32347975 2020. HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey
32343410 2020. COVID-19 in Tuberculosis patients: a report of three cases
32293753 2020. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis
32293709 2020. Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better
32285949 2020. Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19)
32243919 2020. A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab
32380044 ä. Obesity could shift severe COVID-19 disease to younger ages
32251625 2020. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?
32251539 2020. COVID-19 and liver disease
32329563 2020. Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis
32377709 2020. Obesity - a risk factor for increased COVID-19 prevalence, severity and lethality
32347572 2020. Outcome of Parkinson s Disease Patients Affected by COVID-19
32281287 2020. Risk of COVID?19 for patients with obesity
32237212 ä. COVID 19 and the Patient with Obesity ? The Editors Speak Out
32365269 2020. Obesity and severe COVID-19 disease: a strong association
32365275 2020. Obesity accompanying COVID-19: the role of epicardial fat
32352637 2020. Association of Obesity with Disease Severity among Patients with COVID-19
32339391 2020. The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections
32324968 2020. Does high cardiorespiratory fitness confer some protection against pro-inflammatory responses after infection by SARS-CoV-2?
32314871 2020. Targeting the Adipose Tissue in COVID-19
32314868 2020. Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019?
32314861 2020. Obesity is Associated with Severe Forms of COVID-19
32286926 2020. Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19) infections and deaths?
32319118 2020. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover
32345686 2020. Vulnerable Youth and the COVID-19 Pandemic
32317311 2020. Mitigating the Impacts of the COVID-19 Pandemic Response on At-Risk Children
32374541 2020. Diabete et infection a COVID-19
32348046 2020. Rhumatologie et COVID-19
32348045 2020. Maladies autoimmunes dans le contexte de la pandemie COVID-19
32348044 2020. L'hematologie au temps du COVID-19
32348042 2020. Infection a SARS-CoV-2 et transplantation d'organes solides
32302282 2020. Sex- and Gender-specific Observations and Implications for COVID-19
C7149289 2020. Regulatory agencies issue advice on use of NSAIDs for COVID-19
C7187739 ä. Potential Impact of SARS-CoV-2 Infection in HIV-positive Patients in South Africa
32430225 ä. Disparities in the Population at Risk of Severe Illness From COVID-19 by Race/Ethnicity and Income
32387456 ä. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)
32387167 ä. The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019
32376969 ä. COVID-19 outcomes in patients with hematologic disease
32381262 ä. Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission
32402515 ä. Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis
32413819 2020. Vitamin D concentrations and COVID-19 infection in UK Biobank
32408118 2020. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis
32387864 2020. SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects
32388171 2020. SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome
32291196 2020. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?
32389521 2020. COVID-19 infection in patients following hepato-pancreatico-biliary intervention: An early experience
32376408 ä. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study
C7128941 2020. COVID19 Presents High Risk to Older Persons
32376043 ä. Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak
32380288 ä. Genetic susceptibility for COVID-19?associated sudden cardiac death in African Americans
32376098 ä. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
32371279 ä. Therapeutic Strategy for Patients with Coronavirus Disease 2019 During Left Ventricular Assist Device Supports
32305569 2020. Novel Coronavirus Disease 2019 in a Patient on Durable Left Ventricular Assist Device Support
32408961 ä. Clinical course of patients infected with severe acute respiratory syndrome coronavirus 2 soon after thoracoscopic lung surgery
32292915 ä. Severe COVID-19 With ARDS in a Patient on Durable LVAD Support
32380044 2020. Obesity could shift severe COVID-19 disease to younger ages
C7202821 2020. COVID-19: underlying metabolic health in the spotlight
32388230 2020. Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia
32389426 2020. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: ...
32475616 ä. copd w covid....
32360210 2020. Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection
32387757 2020. Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency?
32382684 2020. The mutual effects of COVID-19 and obesity
32389584 ä. Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis
32421537 2020. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)
32292226 ä. Coronavirus: la emergencia geriatrica de 2020...
32418728 ä. Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection
32382258 2020. Active smoking is associated with severity of coronavirus disease 2019 (COVID-19): An update of a meta-analysis
